Partner Headlines - CVS

  1. Cisco PT Raised; SolarCity Upgraded; Disney, CVS PTs Cut

    IBD
  2. CVS Meets, Beats Q4 Views Amid Challenges; Stock Rises

    IBD
  3. Stocks Buffeted Between Short-Term Oil Gains, Global Economic ...

    Benzinga
  4. Polcari: Markets In Turmoil, Euro Bank Stocks Take A Hit

    IBD
  5. 7 Stocks You Should Be Watching Today

    Benzinga
  6. Will Mild Flu Season Knock CVS Health’s Q4 Earnings?

    IBD
  7. Stock Mutual Funds Could See Some Recovery By Midyear

    IBD
  8. Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades

    IBD
  9. Mario Gabelli Comments on CVS Health Corp

    GuruFocus
  10. Apple Supplier Qualcomm, JD Upgraded; Baidu Downgraded

    IBD
  11. Stephen Weiss Sees Value Buys After The Correction

    Benzinga
  12. Steven Romick Sells Microsoft, Walgreens, CVS

    GuruFocus
  13. Amazon.com Turned Its Back On YouTube Video Ads

    IBD
  14. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD
  15. Walgreens-Rite Aid Deal, Generics To Dent McKesson

    IBD
  16. Walgreens Q1 Mixed; Rite Aid Buy Going As Planned

    IBD
  17. Walgreens Sales Expected To Slow Slightly In Q1 2016

    IBD
  18. Rite Aid Sales Slip; WellCare Shifts PBM Work

    IBD
  19. Louis Moore Bacon's Largest 3rd Quarter Trades

    GuruFocus
  20. Evercore Partners Lands Advisory Fees On Big Deals

    IBD
  21. Express Scripts Gets Mixed Reviews After '16 Guidance

    IBD
  22. Fitbit, Under Armour Are Buys; Boeing Downgraded

    IBD
  23. Benzinga's Top Initiations

    Benzinga
  24. First Pacific Advisors Slashes Stake in CVS Health

    GuruFocus
  25. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD
  26. Avon To Sell 80% Of N. America Unit Amid Sales Woes

    IBD
  27. Rite Aid Q3 Hit By Envision Rx Buy, Reaffirms Outlook

    IBD
  28. CVS hikes guidance, dividend

    IBD
  29. CVS Health Hikes Dividend 21%; Target Deal Closed

    IBD
  30. Valeant To Cut Drug Prices In Team-Up With Walgreens

    IBD
  31. Health Care Stocks Play Prominent Roles in Steven Romick's Transactions

    GuruFocus
  32. John Rogers Sells Position in CVS

    GuruFocus
  33. Taking a Look at Barron's 10 Favorite Stocks for 2016

    GuruFocus
  34. Top Performing Industries For December 7, 2015

    Benzinga
  35. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD
  36. UNH CEO: Early ObamaCare Entry A 'Bad Decision'

    IBD
  37. CVS Makes Amgen New BFF

    IBD
  38. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD
  39. CVS Health Announces Formulary and Therapy Strategy for PCSK9 ...

    Benzinga
  40. Drugstore Stocks Fall After UNH's ObamaCare Warning

    IBD
  41. Horizon Slams Express Scripts Amid Pharmacy Dispute

    IBD
  42. Horizon Pharma Soars On Big Q3 Beat, Guidance Raise

    IBD
  43. How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger ...

    GuruFocus
  44. Can Apple Pay Get A Lift From Walgreens Rewards?

    IBD
  45. The Biggest Misunderstanding About Shopify

    FoxBusiness
  46. Walgreens Buys Rite Aid to Avoid Loose Market

    GuruFocus
  47. M&A Hits $4 Trillion At Fastest Pace on Record

    FoxBusiness
  48. Valeant Dumps Philidor, Falls

    IBD
  49. CVS Sneezes, Street Gets Flu

    IBD
  50. No Tricks, Just Treats for Wall Street in October

    FoxBusiness
  51. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  52. Mid-Afternoon Market Update: Aaron's Slides On Earnings Miss; ...

    Benzinga
  53. CVS Health Corp Sharply Lower Following Q3 Report

    Benzinga
  54. How Rite Aid Deal Will Change Walgreens

    GuruFocus
  55. CVS Guides 2016 Low As Walgreens, Rite Aid To Merge

    IBD
  56. Mid-Day Market Update: Cray Surges On Upbeat Results; DigitalGlobe ...

    Benzinga
  57. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  58. Worst Performing Industries For October 30, 2015

    Benzinga
  59. Stocks Off To Wobbly Start; Priceline, LinkedIn Up

    IBD
  60. Herbalife Jabs Bill Ackman Over Troubled Valeant

    FoxBusiness
  61. Mid-Morning Market Update: Markets Mostly Flat; CVS Health Issues ...

    Benzinga
  62. Morning Market Losers

    Benzinga
  63. Weak Data, Rising Stock Futures; Baidu, First Solar, MaxLinear ...

    IBD
  64. Benzinga's Top #PreMarket Losers

    Benzinga
  65. US Stock Futures Edge Higher Ahead Economic Data

    Benzinga
  66. CVS Health Posts In-Line Q3 Earnings, But Issues Weak Profit ...

    Benzinga
  67. 10 Must Watch Stocks for Today

    Benzinga
  68. Earnings Scheduled For October 30, 2015

    Benzinga
  69. Valeant Falls On CVS, Express

    IBD
  70. Valeant Hit As CVS, Express Scripts Dump Philidor

    IBD
  71. Stocks Dip In Light Trade; LinkedIn Soars After Hours

    IBD
  72. Cardinal Health: Dividend Aristocrats Part 17 of 52

    GuruFocus
  73. Walgreens Reverses On Weak Outlook After Rite Aid Buy

    IBD
  74. Walgreens To Buy Rite Aid

    IBD
  75. Walgreens Will Buy Rival Rite Aid In $17.2 Bil Deal

    IBD
  76. Steven Romick Sells CVS, Buys United Technologies

    GuruFocus
  77. Rite Aid Spikes 39% On Reported Walgreens Buy Talks

    IBD
  78. Wall St. Expects CVS Profit Up 12%, Walgreens 9.5%

    IBD
  79. Ulta Beauty Lures Teen Shoppers

    IBD
  80. Target Corp.: Dividend Aristocrats Part 13 of 52

    GuruFocus
  81. Horizon Pharma Counters Depomed Hit On Drug Pricing

    IBD
  82. 4 Ways Ulta Plans To Keep Earning Pretty Profits

    IBD
  83. Ulta, Sephora Steal Teen Girls' Hearts From CVS

    IBD
  84. Sucampo Aims To Be More Than Just A One-Drug Wonder

    IBD
  85. Running On Fumes? Gas Prices, Vaping Boost Tobacco Firms

    IBD
  86. Volkswagen's Mess is a Boon to Rival Stocks

    FoxBusiness
  87. Fast Money Picks For September 22

    Benzinga
  88. Broadcom, Pall Corp. Among Paul Tudor Jones' Recent Buys

    GuruFocus
  89. Goldman Sachs' Stock Picks if Rates Rise

    FoxBusiness
  90. CVS Health Announces New Clinical Affiliations with St. Luke's ...

    Benzinga
  91. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus
  92. The Alfred E. Neuman Stock Market

    Benzinga
  93. Black Monday, Part Deux: Dow Falls 1,000 Points, Several Blue ...

    Benzinga
  94. Three Reasons to Own CVS

    GuruFocus
  95. Walmart Can Overcome Near-Term Challenges

    GuruFocus
  96. Sucampo hits high on EPS

    IBD
  97. Sucampo Stock Hits High On EPS, But CVS Nixes Drug

    IBD
  98. The Cleanup in the Checkout Aisle

    FoxBusiness
  99. CVS Takes Q2 Retail Sales Hit

    IBD
  100. U.S. Equity Markets Pause After Losses

    FoxBusiness
Trading Center